Pdf Viewer

Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia

Logunov, D.Y, et al. (2021) C1
Source:  https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)00234-8/fulltext

The document is not on the server. This browser does not support external PDFs as inline view . Please download the PDF to view it: Download PDF